Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.17 (
ornithine decarboxylase
)
6,351
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Vasoactive intestinal peptide
(
VIP
) is a widely distributed neuropeptide that has been considered a potential regulator of cell growth and differentiation in various tissues, including the gut. To examine this idea, we used a human colon carcinoma cell line (LoVo) as a model system and measured
ornithine decarboxylase
(
ODC
), because this is the rate-limiting enzyme for the formation of polyamines, which are thought to be key factors in regulating cell growth. LoVo cells, grown to about 80% confluence in F-12 medium containing 10% fetal bovine serum, were preincubated for 5 h in low serum medium (1% fetal bovine serum in F-12), and
ODC
activity was determined by measuring 14CO2 liberated from 14C-labeled ornithine.
VIP
caused a dose-related biphasic change in
ODC
, with activity increased at 10 pM, maximal (5-fold increase) at 10 nM, and decreased toward basal at 100 nM to 1 microM. Incubation of cells for 6 days with
VIP
in low serum medium showed similar changes in cell numbers, with growth being increased by doses in the 1 pM to 100 nM range and decreased at higher doses (greater than or equal to 100 nM). Exposure of cells to 5 mM alpha-difluoromethylornithine blocked both the
VIP
-induced increase in cell number and the
VIP
-induced increase in
ODC
activity. Increased
ODC
mRNA was detected after 2 h of exposure to
VIP
, a time at which
ODC
activity peaked after treatment, and the increase in
ODC
mRNA caused by
VIP
was dose-dependent. In related experiments LoVo cells were found to have high affinity
VIP
receptors (Kd = 0.4 nM), as assessed by examination of [125I]
VIP
binding in the presence of varying concentrations of unlabeled
VIP
. Studies of intracellular cAMP revealed a dose-related increase in cAMP in response to
VIP
(ED50 = 11 pM), and the adenylate cyclase activator forskolin increased both
ODC
activity and
ODC
mRNA. The findings support the idea that LoVo cells have
VIP
receptors linked to cAMP which can stimulate cell growth at least in part by increasing
ODC
synthesis and activity, thereby altering the production of polyamines. The decreased growth and
ODC
activity observed with high doses of
VIP
may involve a second messenger other than cAMP.
...
PMID:Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line. 132 53
In parotid, sublingual and submaxillary glands stimulated by continuous intravenous infusion of the neuropeptides substance P or vasoactive intestinal peptide at various doses for 3 h, the concentrations of the polyamines putrescine, spermidine, spermine and N1-acetylspermidine as well as the activity of
ornithine decarboxylase
were determined. This enzyme catalyses the synthesis of putrescine and is the key enzyme in polyamine formation.
Vasoactive intestinal peptide
induced the most marked effects, and the most conspicuous findings were made in the sublingual glands, where the
ornithine decarboxylase
activity was found to have increased more than 100-fold, accompanied by an increased level of putrescine in those glands which were removed immediately after the end of the infusion. When, instead, the glands were removed 5 h after the end of the infusion there was no longer any increase in the activity of
ornithine decarboxylase
or in putrescine concentration, but now spermidine and spermine were found to be increased. Interestingly, the parasympathetic non-adrenergic, non-cholinergic regulation of polyamine metabolism in the major salivary glands of the rat is most predominant in the sublingual glands.
...
PMID:Substance P and vasoactive intestinal peptide influence polyamine metabolism in salivary glands of the rat. 247